Medical - Diagnostics & Research
Compare Stocks
2 / 10Stock Comparison
MTD vs WAT
Revenue, margins, valuation, and 5-year total return — side by side.
Medical - Diagnostics & Research
MTD vs WAT — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Medical - Diagnostics & Research | Medical - Diagnostics & Research |
| Market Cap | $27.00B | $22.78B |
| Revenue (TTM) | $4.03B | $3.77B |
| Net Income (TTM) | $869M | $449M |
| Gross Margin | 57.5% | 55.0% |
| Operating Margin | 27.8% | 17.1% |
| Forward P/E | 28.6x | 24.3x |
| Total Debt | $2.34B | $1.41B |
| Cash & Equiv. | $67M | $588M |
MTD vs WAT — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Mettler-Toledo Inte… (MTD) | 100 | 167.1 | +67.1% |
| Waters Corporation (WAT) | 100 | 174.9 | +74.9% |
Price return only. Dividends and distributions are not included.
Quick Verdict: MTD vs WAT
Each card shows where this stock fits in a portfolio — not just who wins on paper.
MTD carries the broadest edge in this set and is the clearest fit for long-term compounding and valuation efficiency.
- 271.8% 10Y total return vs WAT's 163.2%
- PEG 2.57 vs WAT's 4.69
- PEG 2.57 vs 4.69
WAT is the clearest fit if your priority is income & stability and growth exposure.
- Dividend streak 1 yrs, beta 1.07
- Rev growth 7.0%, EPS growth 0.5%, 3Y rev CAGR 2.1%
- Lower volatility, beta 1.07, Low D/E 55.0%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 7.0% revenue growth vs MTD's 4.0% | |
| Value | PEG 2.57 vs 4.69 | |
| Quality / Margins | 21.6% margin vs WAT's 11.9% | |
| Stability / Safety | Beta 1.07 vs MTD's 1.31 | |
| Dividends | Tie | Neither stock pays a meaningful dividend |
| Momentum (1Y) | +24.9% vs WAT's +3.1% | |
| Efficiency (ROA) | 25.1% ROA vs WAT's 4.6%, ROIC 40.0% vs 20.3% |
MTD vs WAT — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
MTD vs WAT — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
MTD leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
MTD and WAT operate at a comparable scale, with $4.0B and $3.8B in trailing revenue. MTD is the more profitable business, keeping 21.6% of every revenue dollar as net income compared to WAT's 11.9%. On growth, WAT holds the edge at +91.5% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $4.0B | $3.8B |
| EBITDAEarnings before interest/tax | $1.2B | $953M |
| Net IncomeAfter-tax profit | $869M | $449M |
| Free Cash FlowCash after capex | $849M | $264M |
| Gross MarginGross profit ÷ Revenue | +57.5% | +55.0% |
| Operating MarginEBIT ÷ Revenue | +27.8% | +17.1% |
| Net MarginNet income ÷ Revenue | +21.6% | +11.9% |
| FCF MarginFCF ÷ Revenue | +21.1% | +7.0% |
| Rev. Growth (YoY)Latest quarter vs prior year | +8.1% | +91.5% |
| EPS Growth (YoY)Latest quarter vs prior year | +17.2% | -142.9% |
Valuation Metrics
MTD leads this category, winning 4 of 6 comparable metrics.
Valuation Metrics
At 31.5x trailing earnings, MTD trades at a 3% valuation discount to WAT's 32.5x P/E. Adjusting for growth (PEG ratio), MTD offers better value at 2.84x vs WAT's 6.27x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | ||
|---|---|---|
| Market CapShares × price | $27.0B | $22.8B |
| Enterprise ValueMkt cap + debt − cash | $29.3B | $23.6B |
| Trailing P/EPrice ÷ TTM EPS | 31.50x | 32.48x |
| Forward P/EPrice ÷ next-FY EPS est. | 28.56x | 24.30x |
| PEG RatioP/E ÷ EPS growth rate | 2.84x | 6.27x |
| EV / EBITDAEnterprise value multiple | 23.53x | 21.47x |
| Price / SalesMarket cap ÷ Revenue | 6.70x | 7.20x |
| Price / BookPrice ÷ Book value/share | — | 8.15x |
| Price / FCFMarket cap ÷ FCF | 31.81x | 42.21x |
Profitability & Efficiency
MTD leads this category, winning 5 of 7 comparable metrics.
Profitability & Efficiency
On the Piotroski fundamental quality scale (0–9), MTD scores 6/9 vs WAT's 4/9, reflecting solid financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | — | +8.0% |
| ROA (TTM)Return on assets | +25.1% | +4.6% |
| ROICReturn on invested capital | +40.0% | +20.3% |
| ROCEReturn on capital employed | +48.8% | +18.5% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 4 |
| Debt / EquityFinancial leverage | — | 0.55x |
| Net DebtTotal debt minus cash | $2.3B | $820M |
| Cash & Equiv.Liquid assets | $67M | $588M |
| Total DebtShort + long-term debt | $2.3B | $1.4B |
| Interest CoverageEBIT ÷ Interest expense | 16.28x | 6.72x |
Total Returns (Dividends Reinvested)
Evenly matched — MTD and WAT each lead in 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in WAT five years ago would be worth $11,311 today (with dividends reinvested), compared to $10,228 for MTD. Over the past 12 months, MTD leads with a +24.9% total return vs WAT's +3.1%. The 3-year compound annual growth rate (CAGR) favors WAT at 5.6% vs MTD's -1.6% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | -5.9% | -8.5% |
| 1-Year ReturnPast 12 months | +24.9% | +3.1% |
| 3-Year ReturnCumulative with dividends | -4.7% | +17.9% |
| 5-Year ReturnCumulative with dividends | +2.3% | +13.1% |
| 10-Year ReturnCumulative with dividends | +271.8% | +163.2% |
| CAGR (3Y)Annualised 3-year return | -1.6% | +5.6% |
Risk & Volatility
Evenly matched — MTD and WAT each lead in 1 of 2 comparable metrics.
Risk & Volatility
WAT is the less volatile stock with a 1.07 beta — it tends to amplify market swings less than MTD's 1.31 beta. A beta below 1.0 means the stock typically moves less than the S&P 500.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.31x | 1.07x |
| 52-Week HighHighest price in past year | $1525.17 | $414.15 |
| 52-Week LowLowest price in past year | $1052.05 | $275.05 |
| % of 52W HighCurrent price vs 52-week peak | +87.1% | +84.4% |
| RSI (14)Momentum oscillator 0–100 | 53.3 | 62.7 |
| Avg Volume (50D)Average daily shares traded | 147K | 989K |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Wall Street rates MTD as "Hold" and WAT as "Hold". Consensus price targets imply 15.2% upside for WAT (target: $403) vs 12.2% for MTD (target: $1491).
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Hold |
| Price TargetConsensus 12-month target | $1490.83 | $402.57 |
| # AnalystsCovering analysts | 19 | 34 |
| Dividend YieldAnnual dividend ÷ price | — | — |
| Dividend StreakConsecutive years of raises | — | 1 |
| Dividend / ShareAnnual DPS | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | +3.0% | +0.1% |
MTD leads in 3 of 6 categories — strongest in Income & Cash Flow and Valuation Metrics. 2 categories are tied.
MTD vs WAT: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is MTD or WAT a better buy right now?
For growth investors, Waters Corporation (WAT) is the stronger pick with 7.
0% revenue growth year-over-year, versus 4. 0% for Mettler-Toledo International Inc. (MTD). Mettler-Toledo International Inc. (MTD) offers the better valuation at 31. 5x trailing P/E (28. 6x forward), making it the more compelling value choice. Analysts rate Mettler-Toledo International Inc. (MTD) a "Hold" — based on 19 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — MTD or WAT?
On trailing P/E, Mettler-Toledo International Inc.
(MTD) is the cheapest at 31. 5x versus Waters Corporation at 32. 5x. On forward P/E, Waters Corporation is actually cheaper at 24. 3x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Mettler-Toledo International Inc. wins at 2. 57x versus Waters Corporation's 4. 69x.
03Which is the better long-term investment — MTD or WAT?
Over the past 5 years, Waters Corporation (WAT) delivered a total return of +13.
1%, compared to +2. 3% for Mettler-Toledo International Inc. (MTD). Over 10 years, the gap is even starker: MTD returned +271. 8% versus WAT's +163. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — MTD or WAT?
By beta (market sensitivity over 5 years), Waters Corporation (WAT) is the lower-risk stock at 1.
07β versus Mettler-Toledo International Inc. 's 1. 31β — meaning MTD is approximately 22% more volatile than WAT relative to the S&P 500.
05Which is growing faster — MTD or WAT?
By revenue growth (latest reported year), Waters Corporation (WAT) is pulling ahead at 7.
0% versus 4. 0% for Mettler-Toledo International Inc. (MTD). On earnings-per-share growth, the picture is similar: Mettler-Toledo International Inc. grew EPS 3. 7% year-over-year, compared to 0. 5% for Waters Corporation. Over a 3-year CAGR, WAT leads at 2. 1% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — MTD or WAT?
Mettler-Toledo International Inc.
(MTD) is the more profitable company, earning 21. 6% net margin versus 20. 3% for Waters Corporation — meaning it keeps 21. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: WAT leads at 28. 2% versus 27. 8% for MTD. At the gross margin level — before operating expenses — WAT leads at 57. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is MTD or WAT more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Mettler-Toledo International Inc. (MTD) is the more undervalued stock at a PEG of 2. 57x versus Waters Corporation's 4. 69x. Both stocks trade at elevated growth-adjusted valuations, so expected growth needs to materialise. On forward earnings alone, Waters Corporation (WAT) trades at 24. 3x forward P/E versus 28. 6x for Mettler-Toledo International Inc. — 4. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for WAT: 15. 2% to $402. 57.
08Which pays a better dividend — MTD or WAT?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
09Is MTD or WAT better for a retirement portfolio?
For long-horizon retirement investors, Waters Corporation (WAT) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1.
07), +163. 2% 10Y return). Both have compounded well over 10 years (WAT: +163. 2%, MTD: +271. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between MTD and WAT?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.